BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nie X, Liu C, Guo Q, Zheng MJ, Gao LL, Li X, Liu DW, Zhu LC, Liu JJ, Lin B. TMEFF1 overexpression and its mechanism for tumor promotion in ovarian cancer. Cancer Manag Res 2019;11:839-55. [PMID: 30697076 DOI: 10.2147/CMAR.S186080] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Tian J, Yang L, Wang Z, Yan H. MIR503HG impeded ovarian cancer progression by interacting with SPI1 and preventing TMEFF1 transcription. Aging (Albany NY) 2022;14. [PMID: 35771155 DOI: 10.18632/aging.204147] [Reference Citation Analysis]
2 Nie X, Zheng M, Gao L, Hu Y, Zhuang Y, Li X, Zhu L, Liu J, Lin B. Interaction between TMEFF1 and AHNAK proteins in ovarian cancer cells: Implications for clinical prognosis. Int Immunopharmacol 2022;107:108726. [PMID: 35338959 DOI: 10.1016/j.intimp.2022.108726] [Reference Citation Analysis]
3 Boroń D, Zmarzły N, Wierzbik-Strońska M, Rosińczuk J, Mieszczański P, Grabarek BO. Recent Multiomics Approaches in Endometrial Cancer. Int J Mol Sci 2022;23:1237. [PMID: 35163161 DOI: 10.3390/ijms23031237] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhou Q, Zhang Z, Long S, Li W, Wang B, Liang N. Opioids in cancer: The κ‑opioid receptor (Review). Mol Med Rep 2022;25:44. [PMID: 34878160 DOI: 10.3892/mmr.2021.12560] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Nie X, Gao L, Zheng M, Wang C, Wang S, Li X, Qi Y, Zhu L, Liu J, Lin B. Overexpression of TMEFF1 in Endometrial Carcinoma and the Mechanism Underlying its Promotion of Malignant Behavior in Cancer Cells. J Cancer 2021;12:5772-88. [PMID: 34475991 DOI: 10.7150/jca.58524] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Xi Y, Nie X, Wang J, Gao L, Lin B. Overexpression of BMPER in Ovarian Cancer and the Mechanism by which It Promotes Malignant Biological Behavior in Tumor Cells. Biomed Res Int 2020;2020:3607436. [PMID: 32309430 DOI: 10.1155/2020/3607436] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Yu HL, Ma XD, Tong JF, Li JQ, Guan XJ, Yang JH. WTAP is a prognostic marker of high-grade serous ovarian cancer and regulates the progression of ovarian cancer cells. Onco Targets Ther 2019;12:6191-201. [PMID: 31496724 DOI: 10.2147/OTT.S205730] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 8.3] [Reference Citation Analysis]